| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| FHD72812B |
Anti-Human ACVR2A & ACVR2B (SAA0125) mAb, PE |
100 T |
$585.00
|
 |
BUY
|
| FHD72812A |
Anti-Human ACVR2A & ACVR2B (SAA0125) mAb, PE |
50 T |
$405.00
|
|
BUY
|
| FHD33110A |
Anti-Human CD106/VCAM1 Antibody (H6) |
50 µg |
$155.00
|
|
BUY
|
| FHD33110B |
Anti-Human CD106/VCAM1 Antibody (H6) |
100 µg |
$255.00
|
|
BUY
|
| FMJ61012A |
Human Anti-Mouse CD248 (G78) mAb, PE |
50 T |
$405.00
|
|
BUY
|
| FMJ61012B |
Human Anti-Mouse CD248 (G78) mAb, PE |
100 T |
$585.00
|
|
BUY
|
| FHK23610A |
Human IgG1, lambda Isotype Control antibody (HyHEL-10) |
50 µg |
$210.00
|
|
BUY
|
| FHK23610B |
Human IgG1, lambda Isotype Control antibody (HyHEL-10) |
100 µg |
$295.00
|
|
BUY
|
| FHD97920B |
Mouse Anti-Human CD32b/FCGR2B (6G08) mAb |
100µg |
$395.00
|
|
BUY
|
| FHD97920A |
Mouse Anti-Human CD32b/FCGR2B (6G08) mAb |
50µg |
$275.00
|
|
BUY
|
| DHG11010A |
Research Grade Anti-Human CD137/TNFRSF9/4-1BB (AGEN 2373) |
100 ug |
$475.00
|
|
BUY
|
| DHG11010B |
Research Grade Anti-Human CD137/TNFRSF9/4-1BB (AGEN 2373) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHC01902A |
Research Grade Anti-Human CXCL10/IP-10 (NI-0801) |
100µg |
$475.00
|
|
BUY
|
| DHC01902B |
Research Grade Anti-Human CXCL10/IP-10 (NI-0801) |
1mg |
$1,705.00
|
|
BUY
|
| DVV00356A |
Research Grade Anti-SARS-CoV-2 RBD (VIR-7229) mAb |
|
$475.00
|
|
BUY
|
| DVV00356B |
Research Grade Anti-SARS-CoV-2 RBD (VIR-7229) mAb |
|
$1,705.00
|
|
BUY
|
| DHD47902B |
Research Grade Aprutumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47902A |
Research Grade Aprutumab |
100 ug |
$380.00
|
|
BUY
|
| DHC16001A |
Research Grade Bersanlimab |
100 ug |
$380.00
|
|
BUY
|
| DHC16001B |
Research Grade Bersanlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD84002B |
Research Grade Briakinumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD84002A |
Research Grade Briakinumab |
100 ug |
$380.00
|
|
BUY
|
| DHC29904A |
Research Grade Cixutumumab |
100 ug |
$380.00
|
|
BUY
|
| DHC29904B |
Research Grade Cixutumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70106B |
Research Grade Cosibelimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70106A |
Research Grade Cosibelimab |
100 ug |
$380.00
|
|
BUY
|
| DHE01901A |
Research Grade Cusatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHE01901B |
Research Grade Cusatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHA29104B |
Research Grade Drozitumab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHA29104A |
Research Grade Drozitumab |
100 ug |
$430.00
|
|
BUY
|
| DHC12002B |
Research Grade Dusigitumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC12002A |
Research Grade Dusigitumab |
100 ug |
$380.00
|
|
BUY
|
| DHD80804B |
Research Grade Felzartamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD80804A |
Research Grade Felzartamab |
100 ug |
$380.00
|
|
BUY
|
| DHJ53501A |
Research Grade Fezakinumab |
100 ug |
$428.00
|
|
BUY
|
| DHJ53501B |
Research Grade Fezakinumab |
1.0 mg |
$1,562.00
|
|
BUY
|
| DHB95906A |
Research Grade Keliximab |
100 ug |
$380.00
|
|
BUY
|
| DHB95906B |
Research Grade Keliximab |
1.0 ug |
$1,380.00
|
|
BUY
|
| DHA29105A |
Research Grade Lexatumumab |
100 ug |
$380.00
|
|
BUY
|
| DHA29105B |
Research Grade Lexatumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02212A |
Research Grade Lodapolimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02212B |
Research Grade Lodapolimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70107B |
Research Grade Manelimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70107A |
Research Grade Manelimab |
100 ug |
$380.00
|
|
BUY
|
| DHD80803A |
Research Grade Mezagitamab |
100 ug |
$420.00
|
|
BUY
|
| DHD80803B |
Research Grade Mezagitamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD68906A |
Research Grade Mitazalimab |
100 ug |
$380.00
|
|
BUY
|
| DHD68906B |
Research Grade Mitazalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC06701A |
Research Grade Namilumab |
100 ug |
$380.00
|
|
BUY
|
| DHC06701B |
Research Grade Namilumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD46601B |
Research Grade Oleclumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD46601A |
Research Grade Oleclumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ70109B |
Research Grade Opucolimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70109A |
Research Grade Opucolimab |
100 ug |
$380.00
|
|
BUY
|
| DHC27702A |
Research Grade Otelixizumab |
100 ug |
$380.00
|
|
BUY
|
| DHC27702B |
Research Grade Otelixizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC06702B |
Research Grade Otilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC06702A |
Research Grade Otilimab |
100 ug |
$380.00
|
|
BUY
|
| DHD68907A |
Research Grade Vanalimab |
100 ug |
$380.00
|
|
BUY
|
| DHD68907B |
Research Grade Vanalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC12001B |
Research Grade Xentuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC12001A |
Research Grade Xentuzumab |
100 ug |
$380.00
|
|
BUY
|
